Bi-specific monovalent diabodies that are capable of binding cd19 and cd3, and uses thereof
MA40573AUndetermined Publication Date: 2016-03-31MACROGENICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA40573
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2014-09-26
- Filing Date
- 2015-09-22
- Publication Date
- 2016-03-31
Abstract
Cd 19 x cd3 bi-specific monovalent diabodies, and particularly, cd 19 x cd3 bi- specific monovalent fc diabodies, are capable of simultaneous binding to cd 19 and cd3, and are used in the treatment of hematologic malignancies.
Need to check novelty before this filing date? Find Prior Art